BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15949741)

  • 1. Severe left ventricular dysfunction secondary to primary pulmonary hypertension: bridging therapy with bosentan before lung transplantation.
    Brauchlin AE; Soccal PM; Rochat T; Spiliopoulos A; Nicod LP; Trindade PT
    J Heart Lung Transplant; 2005 Jun; 24(6):777-80. PubMed ID: 15949741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension.
    Chin KM; Kingman M; de Lemos JA; Warner JJ; Reimold S; Peshock R; Torres F
    Am J Cardiol; 2008 Jun; 101(11):1669-72. PubMed ID: 18489949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right but not left ventricular function recovers early after living-donor lobar lung transplantation in patients with pulmonary arterial hypertension.
    Toyooka S; Kusano KF; Goto K; Masaomi Y; Oto T; Sano Y; Fuke S; Okazaki M; Ohe T; Kasahara S; Sano S; Date H
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):222-6. PubMed ID: 19577083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of severe pulmonary arterial hypertension.
    Granton J; Mercier O; De Perrot M
    Semin Respir Crit Care Med; 2013 Oct; 34(5):700-13. PubMed ID: 24037636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial experience with bosentan therapy in patients considered ineligible for heart transplantation because of severe pulmonary hypertension.
    Perez-Villa F; Cuppoletti A; Rossel V; Vallejos I; Roig E
    Clin Transplant; 2006; 20(2):239-44. PubMed ID: 16640533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel strategies for the management of right ventricular failure with pulmonary hypertension.
    Meryon IC; Marino P
    Thorax; 2012 Apr; 67(4):368-70. PubMed ID: 22250100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and metabolic recovery of the right ventricle during Bosentan therapy in idiopathic pulmonary arterial hypertension.
    Spindler M; Schmidt M; Geier O; Sandstede J; Hahn D; Ertl G; Beer M
    J Cardiovasc Magn Reson; 2005; 7(5):853-4. PubMed ID: 16353449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined endothelin receptor antagonist and transcatheter interventional therapy of patent ductus arteriosus with severe pulmonary artery hypertension.
    Ussia GP; Mulè M; Caruso E; Aiello R; Tamburino C
    Int J Cardiol; 2007 Apr; 116(3):427-9. PubMed ID: 16875749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with sildenafil and bosentan reverts severe pulmonary hypertension and allows heart transplantation: case report.
    Mogollón MV; Lage E; Cabezón S; Hinojosa R; Ballesteros S; Aranda A; Sobrino JM; Ordóñez A
    Transplant Proc; 2006 Oct; 38(8):2522-3. PubMed ID: 17097987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of patients with idiopathic pulmonary arterial hypertension after listing for transplantation: impact of iloprost and bosentan treatment.
    Dandel M; Lehmkuhl HB; Mulahasanovic S; Weng Y; Kemper D; Grauhan O; Knosalla C; Hetzer R
    J Heart Lung Transplant; 2007 Sep; 26(9):898-906. PubMed ID: 17845928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weaning of epoprostenol in a small infant receiving concomitant bosentan for severe pulmonary arterial hypertension secondary to bronchopulmonary dysplasia.
    Rugolotto S; Errico G; Beghini R; Ilic S; Richelli C; Padovani EM
    Minerva Pediatr; 2006 Oct; 58(5):491-4. PubMed ID: 17008861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bosentan does not improve pulmonary hypertension and lung remodeling in heart failure.
    Jiang BH; Tardif JC; Shi Y; Dupuis J
    Eur Respir J; 2011 Mar; 37(3):578-86. PubMed ID: 20595149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portopulmonary hypertension as an indication for combined heart, lung, and liver or lung and liver transplantation: literature review and case presentation.
    Scouras NE; Matsusaki T; Boucek CD; Wells C; Cooper EA; Planinsic RM; Sullivan EA; Bermudez CA; Toyoda Y; Sakai T
    Liver Transpl; 2011 Feb; 17(2):137-43. PubMed ID: 21280186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse cardiac remodelling in patients with primary pulmonary hypertension after isolated lung transplantation.
    Kasimir MT; Seebacher G; Jaksch P; Winkler G; Schmid K; Marta GM; Simon P; Klepetko W
    Eur J Cardiothorac Surg; 2004 Oct; 26(4):776-81. PubMed ID: 15450572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bosentan effects on hemodynamics and clinical outcome in heart failure patients with pulmonary hypertension awaiting cardiac transplantation.
    Hefke T; Zittermann A; Fuchs U; Schulte-Eistrup S; Gummert JF; Schulz U
    Thorac Cardiovasc Surg; 2012 Feb; 60(1):26-34. PubMed ID: 21432755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease.
    Naeije R
    Proc Am Thorac Soc; 2005; 2(1):20-2. PubMed ID: 16113464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative left ventricular function in different types of pulmonary hypertension: a comparative study.
    Verbelen T; Van De Bruaene A; Cools B; Van Raemdonck D; Delcroix M; Rega F; Meyns B
    Interact Cardiovasc Thorac Surg; 2018 May; 26(5):813-819. PubMed ID: 29300906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe pulmonary arterial hypertension: stratification of medical therapies, mechanical support, and lung transplantation.
    Bartolome SD; Torres F
    Heart Fail Rev; 2016 May; 21(3):347-56. PubMed ID: 27179962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bosentan therapy for pulmonary arterial hypertension.
    Rubin LJ; Badesch DB; Barst RJ; Galie N; Black CM; Keogh A; Pulido T; Frost A; Roux S; Leconte I; Landzberg M; Simonneau G
    N Engl J Med; 2002 Mar; 346(12):896-903. PubMed ID: 11907289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single lung transplantation in rats with fatal pulmonary hypertension.
    Kawaguchi AT; Kawashima Y; Mizuta T; Ishibashi-Ueda H; Kanosue K; Shirakura R; Matsuda H
    J Thorac Cardiovasc Surg; 1992 Sep; 104(3):825-9. PubMed ID: 1387440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.